Summary
The role of the antiproteases α1-proteinase inhibitor (α1PI) and mucus proteinase inhibitor (MPI) in human lung emphysema was investigated by measuring their amount and functional activity against trypsin, leukocyte elastase, and pancreatic elastase in the bronchoalveolar lavage fluid (BALF). In addition, leukocyte elastase was quantified in the lavage samples by measuring the concentration of the elastase-α1Pl-complex. The study population consisted of 38 patients (5 nonsmokers, 8 former smokers, 25 smokers) with aquired emphysema (i.e., emphysema which is not caused by α1PI deficiency), and 44 individuals (16 nonsmokers, 8 former smokers, 20 smokers) without emphysema. No differences were found between patients with and without emphysema in the activities of α1PI and MPI, or in the concentration of α1PI The concentration of MPI was significantly higher in the BALF of patients with emphysema than in that of patients without emphysema (p = 0.025). A significantly higher concentration of elastase-α1PI complex was found in patients with emphysema than in those without emphysema (p = 0.041). This finding could reflect the higher proteinase burden to which patients with emphysema are exposed. The increase of MPI in lavage fluid of patients with emphysema seems to be the result of increased production in emphysematous lungs. However, it remains unclear why patients develop emphysema while showing an increased content of MPI.
Similar content being viewed by others
Abbreviations
- α1PI:
-
α1-proteinase inhibitor
- BALF:
-
bronchoalveolar lavage fluid
- ELISA:
-
enzyme-linked immunosorbent assay
- LEIC:
-
leukocyte elastase inhibitory capacity
- MPI:
-
mucus proteinase inhibitor
- PEIC:
-
pancreatic elastase inhibitory capacity
- TIC:
-
trypsin inhibitory capacity
References
Afford SC, Stockley RA, Kramps JA, Dijkman JH, Burnett D (1985) Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors. Anal Biochem 151:125–130.
Beatty K, Robertie P, Senior RM, Travis J (1982) Determination of oxidised alpha-1-proteinase inhibitor in serum. J Lab Clin Med 100:186–192.
Boudier C, Bieth JG (1989) Mucus proteinase inhibitor: a fastacting inhibitor of leukocyte elastase. Biochim Biophys Acta 995:36–41.
Boudier C, Pelletier A, Pauli G, Bieth JG (1983) The functional activity of α1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and nonsmokers. Clin Chim Acta 132:309–315.
Campbell EJ, Campbell MA (1988) Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J Cell Biol 106:667–676.
Campbell EJ, Senior RM, McDonald JA, Cox DL, Greco JM, Landis JA (1982) Proteolysis by neutrophils: relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest 70:845–852.
Carp H, Janoff A (1978) Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 118:617–621.
Carp H, Miller F, Hoidal JR, Janoff A (1982) Potential mechanisms of emphysema: α1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidised methionin and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 79:2041–2045.
Castillo MJ, Nakajima K, Zimmerman M, Powers JC (1979) Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases. Anal Biochem 99:53–64.
Chase T, Shaw E (1970) Titration of trypsin, plasmin, and thrombin with p-nitrophenyl-p′-guanidinobenzoate HCl. Meth Enzymol 19:20–27.
Chowdhury P, Bone RC, Louria DB, Rayford PL (1982) Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentrations. Am Rev Respir Dis 126:177–179.
Christensen TG, Korthy AL, Snider GL, Hayes JA (1977) Irreversible bronchial goblet cell metaplasia in hamsters with elastase-induced panacinar emphysema. J Clin Invest 59:379–404.
Deutsche Gesellschaft für Pneumologie and Tuberkulose (1988) Empfehlungen zur diagnostischen bronchoalveolären Lavage. Prax Klin Pneumol 42:119–122.
DeWater R, Willems LNA, Van Mujen GNP, Franken C, Fransen JAM, Dijkman JH, Kramps JA (1986) Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am Rev Respir Dis 133:882–890.
Dijkman JH, Franken C, Kramps JA (1987) Antileukoprotease in sputum during bronchial infections. In: Taylor JC, Mittman C (eds) Pulmonary emphysema and proteolysis. Academic Press, New York London, pp 289–297.
Fritz H (1988) Human mucus proteinase inhibitor (human MPI). Biol Chem Hoppe Seyler 369 [Suppl] : 79–82.
Gadek JE, Fells GA, Crystal RG (1979) Cigarette smoke induces functional antiprotease deficiency in the lower respiratory tract of humans. Science 206:1315–1316.
Green NM, Work W (1952) Pancreatic trypsin inhibitor. Biochem J 54:347–352.
Hochstrasser K, Reichert R, Schwarz S, Werle E (1972) Isolierung und Charakterisierung eines Protease Inhibitors aus menschlichem Bronchialsekret. Hoppe-Seylers Z Physiol Chem 353:221–226.
Johnson D, Travis J (1979) The oxidative inactivation of human α1-proteinase inhibitor: further evidence for methionin at the reactive center. J Biol Chem 254:4022–4024.
Kramps JA, Franken C, Meijer CJLM, Dijkman JH (1981) Localization of a low-molecular-weight protease inhibitor in serous cells of the respiratory tract. J Histochem Cytochem 29:712–719.
Kramps JA, Franken C, Dijkman JH (1988) Quantity of anti-leukoprotease relative to α1-proteinase inhibitor in peripheral airspaces of the human lung. Clin Sci 75:351–353.
Kramps JA, Appelhans H, Nikiforov T, Dijkman JH (1989) Trypsin, chymotrypsin and leukocyte elastase are inhibited by the second COOH-terminal domaine of antileukoprotease. Am Rev Respi Dis 139:A201.
Kueppers F, Bromke BJ (1983) Protease inhibitors in tracheobronchial secretions. J Lab Clin Med 101:747–757.
Laurell CB, Eriksson S (1963) The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 15:132–140.
Lellouch J, Claude J-R, Martin J-P, Orssaud G, Zaoui D, Bieth JG (1985) Smoking does not reduce the functional activity of serum alpha-1-proteinase inhibitor. Am Rev Respir Dis 132:818–820.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
Mann HB, Whitney PR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18: 50–60.
Morrison HM, Kramps JA, Burnett D, Stockley RA (1987) Lung lavage fluid from patients with α1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci 72:373–381.
Mullen JBM, Wright JL, Wiggs BR, Pare PD, Hogg JC (1985) Reassessment of inflammation of airways in chronic bronchitis. B M J 291:1235–1239.
Padrines M, Schneider-Pozzer M, Bieth JG (1989) Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils. Am Rev Respir Dis 139:783–790.
Powers JC, Boone R, Carroll DL, Gupton BF, Kam CM, Nishino N, Sakamoto M, Thy PM (1984) Reaction of azapeptides with human leukocyte elastase and porcine pancreatic elastase. J Biol Chem 259:4288–4294.
Schiessler H, Fink E, Fritz H (1976) Acid-stable proteinase inhibitors from human seminal plasma. Methods Enzymol 45:847–859.
Schiessler H, Hochstrasser K, Ohlsson K (1978) Acid stable inhibitors of granulocyte neutral proteases in human mucous secretions: biochemistry and possible biological functions. In: Havemann K, Janoff A (eds) Neutral proteases of human polymorphonuclear leukocytes. Urban & Schwarzenberg, München Wien Baltimore, pp 195–207.
Snider GL, Hayes JA, Franzblau C, Kagam HM, Stone PJ, Korthy AL (1973) Relationship between elastinolytic activity and experimental emphysema-inducing properties of papain preparations. Am Rev Respir Dis 110:254–262.
Stockley RA, Afford SC (1984) Qualitative studies of lung lavage α1-proteinase inhibitor. Hoppe Seylers Z Physiol Chem 365:503–510.
Stone PJ, McGowan SE, Bernardo J, Snider GL, Franzblau C (1983) Functional α1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased. Science 221:1187–1189.
Thurlbeck WM, Ryder RC, Sternby N (1974) A comparative study of the severity of emphysema in necropsy populations in three different countries. Am Rev Respir Dis 109:239–248.
Trefz G, Heck B, Schulz V, Ebert W (1989) Functional activity of the α1-proteinase inhibitor in the serum and bronchoalveolar lavage fluid in acquired pulmonary emphysema. Prax Klin Pneumol 43:446–451.
Wewers MD, Herzyk DJ, Gadek JE (1989) Comparison of smoker and nonsmoker lavage fluid for the range of the association with neutrophil elastase. Am J Respir Cell Mol Biol 1:423–429.
Willems LNA, Otto-Verberne CJM, Kramps JA, tenHaveOpbroek AAW, Dijkman JH (1986) Detection of antileukoprotease in connective tissue of the lung. Histochemistry 86:165–168.
Willems LNA, Kramps JA, Stijnen T, Sterk PJ, Weening JJ, Dijkman JH (1989) Antileukoprotease-containing bronchiolar cells. Am Rev Respir Dis 139:1244–1250.
Zimmerman M, Ashe B, Yurewicz EC, Patel G (1977) Sensitive assays for trypsin, elastase, and chymotrypsin using new fluorogenic substrates. Anal Biochem 78:47–51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trefz, G., Schließer, J., Heck, B. et al. α1-Proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema. Clin Investig 70, 269–276 (1992). https://doi.org/10.1007/BF00184661
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00184661